Background: Metamemory training (MMT) offers a potential nonpharmacological approach to enhance cognitive function in individuals with mild cognitive impairment (MCI). While digital cognitive training improves accessibility, the effectiveness of mobile app–based MMT has not…
Continue Reading
What You Should Know:
– Two newly published peer-reviewed studies validate that Linus Health’s AI-driven, 3-minute digital assessment can concurrently detect cognitive impairment and predict underlying Alzheimer’s pathology.
– This “multiplexing” capability allows primary care providers…
Continue Reading
Henry O’Connell, CEO and co-founder of Canary Speech
Vocal biomarker data has come a long way in a short amount of time. No longer relegated to the pages of science fiction, the power of the…
Continue Reading
Artificial intelligence models analyzing speech show remarkable promise for identifying cognitive decline, achieving performance comparable to clinical assessments. However, their “black box” nature poses significant barriers to clinical adoption, as healthcare professionals require transparent…
Continue Reading
(L to R) Pam Fearns, chief nursing information officer, Stephanie Bray, lead digital midwife, and Astrid Lefevre, lead digital nurse at Stockport NHS Foundation Trust (Credit: Stockport NHS FT)
Stockport NHS Foundation Trust has…
Continue Reading
What You Should Know:
– Moneta Health, a brain health company pioneering cognitive rehabilitation therapy through AI-powered delivery secures $4.5M with investment from True Ventures and Health2047 (the American Medical Association’s venture studio).
– The investment…
Continue Reading
What You Should Know:
– NewDays, a company offering a science-backed cognitive health treatment program, has announced an oversubscribed $7M seed funding round from General Catalyst and Madrona.
– The company is also expanding its services…
Continue Reading
What You Should Know:
– Neuroglee Health, a leader in value-based dementia care, has announced an expanded collaboration with Mayo Clinic to deliver comprehensive virtual cognitive and dementia care to patients and provide dedicated support…
Continue Reading
Background: Recent studies demonstrated the validity, reliability and accuracy of consumer smartwatches for measuring daily steps in people with Parkinson’s disease (PwPD). However, no study to date estimated the minimal clinically important difference (MCID)…
Continue Reading
Cognitive impairment is a frequent complication of Parkinson’s disease (PD), affecting up to half of newly diagnosed patients. To improve early detection and risk assessment, we developed machine learning models using clinical data from…
Continue Reading
